Literature DB >> 33026073

Tripartite relationship between gut microbiota, intestinal mucus and dietary fibers: towards preventive strategies against enteric infections.

Thomas Sauvaitre1,2, Lucie Etienne-Mesmin1, Adeline Sivignon3, Pascale Mosoni1, Christophe M Courtin4, Tom Van de Wiele2, Stéphanie Blanquet-Diot1.   

Abstract

The human gut is inhabited by a large variety of microorganims involved in many physiological processes and collectively referred as to gut microbiota. Disrupted microbiome has been associated with negative health outcomes and especially could promote the onset of enteric infections. To sustain their growth and persistence within the human digestive tract, gut microbes and enteric pathogens rely on two main polysaccharide compartments, namely dietary fibers and mucus carbohydrates. Several evidences suggest that the three-way relationship between gut microbiota, dietary fibers and mucus layer could unravel the capacity of enteric pathogens to colonise the human digestive tract and ultimately lead to infection. The review starts by shedding light on similarities and differences between dietary fibers and mucus carbohydrates structures and functions. Next, we provide an overview of the interactions of these two components with the third partner, namely, the gut microbiota, under health and disease situations. The review will then provide insights into the relevance of using dietary fibers interventions to prevent enteric infections with a focus on gut microbial imbalance and impaired-mucus integrity. Facing the numerous challenges in studying microbiota-pathogen-dietary fiber-mucus interactions, we lastly describe the characteristics and potentialities of currently available in vitro models of the human gut.
© The Author(s) 2020. Published by Oxford University Press on behalf of FEMS.

Entities:  

Keywords:  zzm321990 in vitro gut models; dietary fibers; enteric pathogens; gut microbiota; mucus

Year:  2021        PMID: 33026073     DOI: 10.1093/femsre/fuaa052

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  5 in total

1.  Role of mucus-bacteria interactions in Enterotoxigenic Escherichia coli (ETEC) H10407 virulence and interplay with human microbiome.

Authors:  Lucie Etienne-Mesmin; Stéphanie Blanquet-Diot; Thomas Sauvaitre; Josefien Van Landuyt; Claude Durif; Charlène Roussel; Adeline Sivignon; Sandrine Chalancon; Ophélie Uriot; Florence Van Herreweghen; Tom Van de Wiele
Journal:  NPJ Biofilms Microbiomes       Date:  2022-10-20       Impact factor: 8.462

2.  Lentils and Yeast Fibers: A New Strategy to Mitigate Enterotoxigenic Escherichia coli (ETEC) Strain H10407 Virulence?

Authors:  Thomas Sauvaitre; Florence Van Herreweghen; Karen Delbaere; Claude Durif; Josefien Van Landuyt; Khaled Fadhlaoui; Ségolène Huille; Frédérique Chaucheyras-Durand; Lucie Etienne-Mesmin; Stéphanie Blanquet-Diot; Tom Van de Wiele
Journal:  Nutrients       Date:  2022-05-21       Impact factor: 6.706

3.  Commentary: The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and Its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model.

Authors:  Yang Yu; Cun Liu; Jingyang Liu; Jing Zhuang; Changgang Sun
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 4.  New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer.

Authors:  Lu Lu; Jiahuan Dong; Yujing Liu; Yufan Qian; Guangtao Zhang; Wenjun Zhou; Aiguang Zhao; Guang Ji; Hanchen Xu
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

5.  The Effect of Short-Term Consumption of Lactic Acid Bacteria on the Gut Microbiota in Obese People.

Authors:  Inna Burakova; Yuliya Smirnova; Mariya Gryaznova; Mikhail Syromyatnikov; Pavel Chizhkov; Evgeny Popov; Vasily Popov
Journal:  Nutrients       Date:  2022-08-18       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.